How to Compare Financial Ratios Across Industries

A price-to-earnings ratio of 15 can be a bargain for a growing software firm but a red flag for a mature utility. Comparing financial ratios across industries without accounting for structural differences leads to false conclusions. The correct method groups companies by sector, adjusts for business-model divergence, and uses relative peers as benchmarks instead of rigid universal thresholds.

Why Universal Benchmarks Fail

Investors often internalize rules of thumb: “A price-to-earnings ratio above 20 is expensive.” or "Debt-to-equity over 1.0 is risky." These figures misfire because they ignore industry norms.

Banks operate with debt-to-equity ratios of 8–12 and remain stable; it’s how their business model works (borrowing short-term deposits to lend long-term). Software firms sustain debt-to-equity below 0.3 and hoard cash. An analyst comparing a bank and a software company using the same leverage threshold will incorrectly classify the bank as reckless and the software firm as conservative.

Similarly, cloud-computing companies with negative earnings due to heavy R&D spending can trade at P/E ratios that seem absurd (100+) until you compare them to peers achieving the same growth trajectory. Mature industrial manufacturers with P/E ratios of 8–10 are not cheap universally; they’re trading at the historical norm for low-growth, capital-intensive sectors.

The problem: financial ratios embed the business model. Comparing across business models without adjustment is comparing apples to refinery equipment.

Step 1: Define Your Peer Group

Same industry, similar scale, comparable business model.

A peer group for Johnson & Johnson (diversified pharma/consumer health) is not all healthcare companies. It’s large-cap, multinational pharmaceutical and consumer-healthcare firms: Pfizer, Merck, Novartis, AstraZeneca. Smaller regional pharma companies or biotech firms without commercialized products have different cost structures and capital requirements.

For Nvidia (semiconductor design and AI chip sales), peers include:

• Advanced Micro Devices (competitive chip architect)
• Broadcom (semiconductor/infrastructure IP)
• Marvell Technology (semiconductor design)

Not Intel (manufacturing-heavy, foundry model) or software peers like Microsoft. Nvidia’s business—design and fabless manufacturing through partners—differs fundamentally from Intel’s integrated model, and their ratios will diverge accordingly.

The peer group should be 8–15 companies. Fewer than 8 and outliers distort the median; more than 15 and you risk including non-peers. Within the group, order by market capitalization, revenue, or profit margin to spot size-driven differences. A $500 billion company and a $2 billion startup in “the same industry” face different competitive and financing environments.

Step 2: Calculate Relative Metrics

Once you’ve assembled peers, compute the median (or mean) for each key ratio:

• Price-to-earnings ratio
• Price-to-sales ratio
• Price-to-book ratio
• Return on equity
• Return on assets
• Debt-to-equity
• Current ratio
• Profit margin (gross, operating, net)
• Asset turnover
• Interest coverage

Example peer group: U.S. large-cap drugmakers

If a new entrant in pharma has a P/E of 22, it’s trading 51% above the peer median. That might be justified if growth is higher, but you’d investigate the earnings growth rate. If earnings growth matches peers (5–7% annually), the valuation is stretched. If the company is growing earnings at 18–20%, a higher P/E is defensible.

Step 3: Investigate Outliers

A company with a debt-to-equity of 2.5 while peers are at 0.6 is a red flag, but not always a problem. Ask:

1. Is there a strategic reason? Did the company pursue a large acquisition or invest in a capital-intensive facility? Temporary high leverage is different from structural.

2. Is debt composition favorable? A company with 2.5× debt-to-equity but long-term, fixed-rate borrowing at 3% is safer than one with 1.0× leveraged on short-term, floating-rate debt at 6%.

3. Does cash flow support it? A company with high leverage but strong free cash flow can service debt; one with weak cash flow cannot.

4. Is it an outlier or a signal? If one peer has high leverage, investigate why. If all peers have risen to 1.2× while this company stays at 0.6, it may be under-leveraged and forgoing profitable investments.

Step 4: Account for Business-Model Differences Within a Sector

Even within the same industry, business models diverge. This requires sub-adjustments.

Retail banking vs. investment banking:

• Retail banks: high leverage, low return on assets (0.5–1.0%), high interest margins (2–3%)
• Investment banks: lower leverage, high return on assets (0.8–1.5%), variable compensation tied to market activity
• Comparing a retail bank’s ROA to an investment bank’s is meaningless without context.

Capital-intensive vs. capital-light software:

• A semiconductor manufacturer requires $10 billion in plant and equipment to ship chips; asset turnover is low (0.5–0.7×).
• A SaaS (software-as-a-service) company needs a data center and engineering but scales with minimal incremental assets; asset turnover is high (2–4×).
• Comparing asset turnover directly is useless. Instead, compare return on assets (profit generated per dollar of capital invested), which normalizes for the capital intensity difference.

Growth vs. mature within the same sector:

• Young biotech firms burn cash on R&D; profit margins are negative; debt-to-equity is high. Mature pharma has positive margins and moderate leverage.
• Comparing these cohorts by a universal threshold is nonsense. Instead, separate them: assess young biotech against young biotech peers; mature pharma against mature peers.

Step 5: Build a Scorecard

Rank the company against peers on each metric:

This scorecard reveals: the company is fairly valued (moderate P/E premium justified by higher ROE), has reasonable leverage, and operates profitably. No single metric condemns or endorses it; the pattern informs judgment.

Common Pitfalls

Pitfall 1: Mixing growth and cyclical stocks.
Healthcare-IT (high growth) and healthcare providers (cyclical, mature) are in “healthcare” but behave differently. Compare within subsets.

Pitfall 2: Ignoring regulatory environment.
Utilities are heavily regulated and can sustain lower returns on equity (8–10%) because capital is guaranteed a return. Industrial firms are not; a 10% ROE for an unregulated manufacturer is poor. Don’t compare them directly.

Pitfall 3: Extrapolating from one ratio.
A company with a low P/E might have high leverage, thin margins, and declining market share. The low P/E reflects those risks. Buying it as “cheap” ignores the full picture.

Pitfall 4: Static peer groups.
Industries evolve. A peer group from 2015 may not reflect 2026 realities (disruption, consolidation, new entrants). Review and update annually.

Pitfall 5: Confusing “different” with “wrong.”
A company with a P/E of 25 while peers are at 15 is not automatically overvalued. It might deserve the premium if growth is faster, margins are expanding, or it has competitive advantages. The premium is only excessive if unjustified by fundamentals.

See also